Literature DB >> 2993290

The A1 adenosine receptor. Identification of the binding subunit by photoaffinity cross-linking.

G L Stiles, D T Daly, R A Olsson.   

Abstract

Adenosine modifies the catalytic activity of adenylate cyclase through both inhibitory (A1 or Ri) as well as stimulatory (A2 or Ra) cell surface receptors. We developed 125I-labeled N6-2-(4-aminophenyl)ethyladenosine as a selective ligand to probe the structure of A1 receptors. The binding of this radioligand to rat cerebral cortex or adipocyte membranes is saturable, reversible, and of high affinity (KD approximately 2 nM). A1 receptor agonists antagonize binding stereoselectivity and with a potency order appropriate for A1 receptors. The heterobifunctional cross-linking reagent N-succinimidyl-6-(4-azido-2-nitrophenylamino)hexanoate covalently couples the radioligand to a protein of Mr = 38,000 in both tissues as demonstrated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography. Inhibition of covalent labeling by adenosine analogs exhibited the stereoselectivity and potency order typical of A1 receptor ligands. Guanine nucleotides reduced both specific binding and covalent incorporation of the radioligand, evidence that the radioligand is an A1 receptor agonist. These results suggest that the A1 receptor binding subunit of both brain and adipocytes resides on a protein of Mr = 38,000. The new radioligand should prove useful in studying the structure and regulation of A1 receptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993290

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Distinct pathways of desensitization of A1- and A2-adenosine receptors in DDT1 MF-2 cells.

Authors:  V Ramkumar; M E Olah; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1991-11       Impact factor: 4.436

2.  Target size of the adenosine Ri receptor.

Authors:  L T Frame; S M Yeung; J C Venter; D M Cooper
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

3.  Cloning, expression, and characterization of the unique bovine A1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis.

Authors:  M E Olah; H Ren; J Ostrowski; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

4.  28 kDa adenosine-binding proteins of brain and other tissues.

Authors:  K Ravid; R A Rosenthal; S R Doctrow; J M Lowenstein
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

5.  Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.

Authors:  C Gallo-Rodriguez; X D Ji; N Melman; B D Siegman; L H Sanders; J Orlina; B Fischer; Q Pu; M E Olah; P J van Galen
Journal:  J Med Chem       Date:  1994-03-04       Impact factor: 7.446

6.  A binding site model and structure-activity relationships for the rat A3 adenosine receptor.

Authors:  P J van Galen; A H van Bergen; C Gallo-Rodriguez; N Melman; M E Olah; A P IJzerman; G L Stiles; K A Jacobson
Journal:  Mol Pharmacol       Date:  1994-06       Impact factor: 4.436

7.  A new high affinity, iodinated adenosine receptor antagonist as a radioligand/photoaffinity crosslinking probe.

Authors:  G L Stiles; K A Jacobson
Journal:  Mol Pharmacol       Date:  1987-08       Impact factor: 4.436

8.  125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.

Authors:  M E Olah; C Gallo-Rodriguez; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1994-05       Impact factor: 4.436

9.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Authors:  Q Y Zhou; C Li; M E Olah; R A Johnson; G L Stiles; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

10.  Identification of an adenosine receptor domain specifically involved in binding of 5'-substituted adenosine agonists.

Authors:  M E Olah; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1994-07-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.